BIOTECH
-
With €30m, BIOLEVATE wants to turn AI into a compliance tool for drugmakers
Biolevate has raised a €30 million Series A to deploy its artificial intelligence platform across regulated life sciences operations. The…
Read More » -
NOVADIP raises €10.4 million to fund NVD003’s final regulatory mile
Belgian biotech Novadip Biosciences has secured €10.4 million through a convertible loan from New Science Ventures and its existing investors.…
Read More »